Results 121 to 130 of about 15,828 (290)

Acute profound thrombocytopenia following C7E3 Fab (abciximab) therapy: Case reports, review of the literature and implications for therapy [PDF]

, 1999
Steven J. Jubelirer, Beth A. Koenig, Mark C. Bates   +2 more
openalex   +1 more source

Assessment of change of coronary artery flow using corrected TIMI frame count following abciximab adminstration during primary angioplasty for acute myocardial infarction [PDF]

, 2000
Hae Ok Jung, Ki Bae Seung, Jungwon Jang, Sang Hyun Lim, Ki Yuk Jang, Hyo Young Lim, Wook Sung Chung, Jong Jin Kim, Jang Sung Chae, Jae Hyung Kim, Soon Jo Hong, Kyu Bo Choi   +11 more
openalex   +1 more source

Cardiovascular involvement in Kawaski Disease [PDF]

, 2005
This article contains a case report of a 19 month old child with Kawasaki Disease who developed bilateral giant coronary artery aneurysms.peer ...
Chintala, Kavitha, Forbes, T.J., Reddy, S.V.   +2 more
core  

Adjuvant antithrombotic therapy in ST-elevation myocardial infarction: A narrative review

Revista Portuguesa de Cardiologia, 2019
This article reviews the major pharmacologic features of, and clinical evidence on, adjuvant medical therapy in patients with ST-elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention.
Daniel Caldeira, Hélder Pereira
doaj  

Abciximab in Acute Ischemic Stroke [PDF]

, 2000
The Abciximab in Ischemic Stroke Investigators
openalex   +1 more source

Fatal Hemorrhagic Transformation of Acute Cerebral Infarction After the Use of Abciximab [PDF]

, 2000
Raymond T.F. Cheung, David S.W. Ho
openalex   +1 more source

Use of abciximab for aneurysm coiling [PDF]

Anaesthesia, 2006
S. Kapur, E. J. da Silva
openaire   +3 more sources

Adverse Drug Effect Profiles of Gp2b/3a Inhibitors: A Comparative Review of the Last Two Decades. [PDF]

Cureus, 2023
Hasan N, Jauregui W, Zubair M, Pushparajan VK, Carson BJ, Attaluri DM, Dixon D, Jaisinghani A, Chuecos A, Ravichandran D.   +9 more
europepmc   +1 more source

Attainment and Maintenance of Platelet Inhibition Through Standard Dosing of Abciximab in Patients Undergoing Percutaneous Coronary Intervention [PDF]

, 2000
Dean J. Kereiakes
openalex   +1 more source

Intracoronary abciximab.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
Here we report the potential benefits of the use of intracoronary abciximab during percutaneous coronary intervention for an acute myocardial infarction.
S Ruiz, Bustillo, P, Stella, P A F M, Doevendans   +2 more
openaire   +1 more source